Dynamic Splinting for Excessive Pronation Following CVA

Dynamic Splinting for Excessive Pronation Following CVA: A Randomized, Controlled Tial

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00900692

Acronym

SupPro Botox

Enrollment

Registered

2009-05-13

Start date

2009-05-31

Completion date

2016-10-31

Last updated

2013-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pronation Contracture

Keywords

Excessive pronation, CVA, Forearm, Excessive pronation following CVA

Brief summary

The purpose of this study is to examine range of motion and lasting effects of Botox injections along with the use of the Supination Dynasplint.

Interventions

DEVICEDynasplint

Dynamic splinting utilizes the protocols of Low-Load Prolonged Stretch (LLPS) with calibrated adjustable tension to increase Total End Range Time (TERT)to reduce contracture. The Dynasplint or Experimental group will add this therapy to their standard of care regimen

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Patients enrolled will have been diagnosed with excessive pronation following a stroke and will display the following symptoms: * Pronation Contracture * Ability to provide consent and follow directions as related to the protocol

Exclusion criteria

* Treatment with Benzodiazepines * Treatment with Baclofen (pump or oral) * Treatment with Dantrolene sodium * Treatment with Tizanidine

Design outcomes

Primary

Measure	Time frame
ROM changes with use of treatment	20 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026